All Stories

  1. Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinants
  2. Progression of GBA1 severe and risk variants: a longitudinal mixed model analysis
  3. Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study
  4. Phenotypic Heterogeneity of Movement Behaviors and Its Association With Cardiometabolic Health Using Data From the ORISCAV-LUX 2 Study
  5. Psychosocial burden in type 1 diabetes: a cross-sectional network analysis in the SFDT1 study
  6. Severity of complications is associated with impaired health‐related quality of life in people with type 1 diabetes
  7. Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes—the critical role of hypoglycaemia awareness: results from the SFDT1 study
  8. Role of the exposome in mental disorders: a scoping review protocol
  9. Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review
  10. Long COVID Companion-App: Entwicklung eines digitalen Gesundheitswerkzeuges zur Unterstützung von Personen mit Long COVID
  11. Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study
  12. Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
  13. Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis
  14. Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review (Preprint)
  15. Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort
  16. Readiness of adults with type 1 diabetes and diabetes caregivers for diabetes distress monitoring using a voice-based digital health solution: insights from the PsyVoice mixed methods study
  17. The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta‐analysis
  18. A voice-based algorithm can predict type 2 diabetes status in USA adults: Findings from the Colive Voice study
  19. Fear of hypoglycemia and sleep in children with type 1 diabetes and their parents
  20. Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1
  21. The transformative role of artificial intelligence in diabetes care and research
  22. Understanding unexpectedly stable trajectories of functional mobility in people with Parkinson’s disease: A mixed methods study
  23. Progression of GBA1 Gaucher-related and Parkinson’s-risk variants: A longitudinal mixed model analysis
  24. Heterogeneity of glycaemic phenotypes in type 1 diabetes
  25. Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
  26. Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study
  27. Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism
  28. Sex-specific progression of Parkinson’s disease: A longitudinal mixed-models analysis
  29. Sex-specific progression of Parkinson’s disease: A longitudinal mixed-models analysis
  30. Mixed-methods study protocol to identify expectations of people with type 1 diabetes and their caregivers about voice-based digital health solutions to support the management of diabetes distress: the PsyVoice study
  31. Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease
  32. Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study
  33. Substituting device-measured sedentary time with alternative 24-hour movement behaviours: compositional associations with adiposity and cardiometabolic risk in the ORISCAV-LUX 2 study
  34. Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study
  35. Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study (Preprint)
  36. Machine learning for predicting neurodegenerative diseases in the general older population: a cohort study
  37. Device-measured physical activity and sedentary time in a national sample of Luxembourg residents: the ORISCAV-LUX 2 study
  38. Associations Between Wearable-Specific Indicators of Physical Activity Behaviour and Insulin Sensitivity and Glycated Haemoglobin in the General Population: Results from the ORISCAV-LUX 2 Study
  39. Recommendations for Successful Implementation of the Use of Vocal Biomarkers for Remote Monitoring of COVID-19 and Long COVID in Clinical Practice and Research
  40. Discovery and Analytical Validation of a Vocal Biomarker to Monitor Anosmia and Ageusia in Patients With COVID-19: Cross-sectional Study
  41. 6Développement de nouveaux ”endpoints” cliniques à l'aide de biomarqueurs numériques basés sur la voix pour le suivi à distance, en vie réelle, de patients en recherche clinique: exemple de biomarqueurs vocaux pour le suivi du statut symptomatique de p...
  42. Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study
  43. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study
  44. Global diabetes burden: analysis of regional differences to improve diabetes care
  45. Validation of a Parkinson’s Disease Questionnaire-39-based Functional Mobility Composite Score (FMCS) in people with Parkinson’s disease.
  46. The Nutri-Score nutrition label
  47. Use of vocal biomarkers for remote monitoring of Covid-19 and Long Covid in clinical practice and research: recommendations for successful implementation (Preprint)
  48. Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study
  49. Associations between physical activity prior to infection and COVID-19 disease severity and symptoms: results from the prospective Predi-COVID cohort study
  50. Development of a vocal biomarker for fatigue monitoring in people with COVID-19
  51. Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study
  52. Association between Dietary Factors and Constipation in Adults Living in Luxembourg and Taking Part in the ORISCAV-LUX 2 Survey
  53. Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study
  54. Unraveling the concepts of distress, burnout, and depression in type 1 diabetes: A scoping review
  55. Digital Health Interventions among People Living with Frailty: A Scoping Review
  56. Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study
  57. Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study
  58. Intricate relationships between frailty and diabetes: where do we go from here?
  59. Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study (Preprint)
  60. Identifying hotspots of cardiometabolic outcomes based on a Bayesian approach: The example of Chile
  61. Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers
  62. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
  63. Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
  64. Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers (Preprint)
  65. Multi-Scale Multivariate Models for Small Area Health Survey Data: A Chilean Example
  66. Diabetes can accelerate frailty progression in older people
  67. Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study
  68. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study
  69. Multiplicative effect of mild depressive symptoms with diabetes on other chronic conditions
  70. Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study
  71. Agreement Between 35 Published Frailty Scores in the General Population
  72. Abstract P011: Predictive Ability of 35 Frailty Scores for Cardiovascular Events in the General Population
  73. Mortality prediction of 35 frailty scores in a 7-years follow-up study in elderly general population
  74. Polluants organiques persistants et contaminants associés au plastique et risque d’obésité : revue systématique
  75. Assessment of body-image perception and attitudes in obesity
  76. A Randomized Controlled Study of Virtual Reality Exposure Therapy and Cognitive-Behaviour Therapy in Panic Disorder with Agoraphobia
  77. Incidencia de displasia broncopulmonar: Incidence